✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Orchid Pharma Ltd.

ORCHPHARMA

Market Cap
₹4,282 Cr.
P/E
38.82

Orchid Pharma Ltd.

  • Orchid Pharma
  • Sequent Scientific
  • Unichem Lab
FAQs on Orchid Pharma Ltd. Shareprice

Orchid Pharma has given better returns compared to its competitors.
Orchid Pharma has grown at ~86.34% over the last 7yrs while peers have grown at a median rate of 13.56%

Orchid Pharma is not expensive.
Latest PE of Orchid Pharma is 37.28, while 3 year average PE is 50.15.
Also latest EV/EBITDA of Orchid Pharma is 34.15 while 3yr average is 44.82.

View FAQ's On Business
Growth Table
  • Orchid Pharma Ltd.
  • Sequent Scientific
  • Unichem Lab
Balance Sheet
  • Orchid Pharma Ltd.
  • Sequent Scientific
  • Unichem Lab
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Orchid Pharma Ltd.
  • Sequent Scientific
  • Unichem Lab
Cash Flow
  • Orchid Pharma Ltd.
  • Sequent Scientific
  • Unichem Lab
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Orchid Pharma Ltd.
  • Sequent Scientific
  • Unichem Lab
Quarterly Results
  • Orchid Pharma Ltd.
  • Sequent Scientific
  • Unichem Lab
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Orchid Pharma Ltd. Financials

Balance sheet of Orchid Pharma is strong.
It shouldn't have solvency or liquidity issues.

Yes, The debt of Orchid Pharma is increasing.
Latest debt of Orchid Pharma is -₹79.49 Crs as of Sep-24.
This is greater than Mar-24 when it was -₹398.61 Crs.

Yes, profit is increasing.
The profit of Orchid Pharma is ₹110 Crs for TTM, ₹92.17 Crs for Mar 2024 and ₹46.32 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Orchid Pharma latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech